Skip to main content
. 2006 Apr;188(8):3099–3109. doi: 10.1128/JB.188.8.3099-3109.2006

TABLE 2.

Oligonucleotides used in this studya

Oligonucleotide Sequence (5′ to 3′) Description and position
abrB-F CCATCGATCGGCATCTTGAAACCTCCTA ClaI; 5′ end of PabrB
abrB-R GGAATTCCTTCATAAACATTCTCCTCCC EcoRI; 3′ end of PabrB
spoIIE-F CCCAAGCTTGGCGGTGTAGCTCAGCTGGC HindIII; 5′ end of PspoIIE
spoIIE-R TTCTGCAGTTCCATTCCTCTCATCTCCCACCTG PstI; 3′ end of PspoIIE
cotC-F GGGGTACCCAGAATTTAAACAAGCAACAAGCGG KpnI; 5′ end of PcotC
cotC-R-transl CCCAAGCTTGTAGTGTTTTTTATGCTTTTTATACTCTAC HindIII; 3′ end of cotC
kinA-F GCGGATCCGATGACGATGACAAAATGGAACAGGATACGCAGCATGTTAAC BamHI; 5′ end of kinA
kinA-R GCGCAAGCTTATTTTTTTGGAAATGAAATTTTAAACGC HindIII; 3′ end of kinA
PDG-F AAGGAGGAAGCAGGTATGAGAGGATCGCATCACCATCACCATCAC LIC; 5′ end of pQE30-kinA
PDG-R GACACGCACGAGGTTATTTTTTTGGAAATGAAATTTTAAACGCTG LIC; 3′ end of pQE30-kinA
a

Relevant restriction sites are underlined. Abbreviations: F, forward; R, reverse; LIC, ligation-independent cloning. Note that the use of the primers for abrB and spoIIE resulted in transcriptional GFP fusions; the primer for cotC resulted in a C-terminal translational GFP fusion under the control of its own promoter; and the primer for kinA resulted in a GFP fusion under the control of an IPTG-inducible promoter.